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Case Report
Summary
Sudden onset of horizontal diplopia in an elderly patient can be 
due to giant cell arteritis. Although the patient reported was a 
vasculopath, a concurrent headache, mild reduction in visual 
acuity, scalp tenderness and raised inlammatory markers lead 
to a diagnosis of giant cell arteritis (GCA) and commencement 
of steroids. Ater an inconclusive temporal artery biopsy and 
resolution of visual acuity, the steroids were stopped, but within this 
time her hypertensive and diabetic treatment had been markedly 
disturbed. he rationale for treatment is discussed.
Case Report
A 70 year old lady presented to her routine diabetic retinopathy 
clinic appointment complaining of recent onset diplopia and mild 
headache. As well as having poorly controlled diabetes, she also 
sufered a myriad of other related illnesses including hypertension, 
renal failure and peripheral vascular disease which had resulted 
in a let below knee amputation. She had endured a prolonged 
hospital stay of over eight months duration the previous year due 
to infected leg ulcers.
On direct questioning, her mild headache was globally distributed, 
although she reported some tenderness on combing her hair in the 
let temporal region. he diplopia was horizontal and had started 
that morning. She had no recent weight loss, anorexia, malaise, 
fever or joint pains. She had no jaw claudication or myalgia.
On examination, her best corrected visual acuity was 6/6 in the 
right eye and 6/12 in the let eye. he let eye vision had decreased 
slightly from 6/9+1 at the previous visit four months earlier. here 
was no relative aferent pupillary defect and Ishihara colour plate 
testing revealed full colour vision bilaterally. Ocular motility 
testing revealed a let esotropia and decreased let lateral gaze. 
Anterior segments were healthy and intraocular pressures were 
within the normal range. Dilated examination revealed bilateral 
non proliferative diabetic retinopathy, no clinically signiicant 
macular oedema and healthy pink optic discs. here was mild 
temporal artery tenderness on the let hand side. Neither temporal 
artery was pulsatile. Humphrey automated visual ield testing was 
unremarkable. A diagnosis of sixth nerve palsy possibly secondary 
to GCA was made.
On presentation, her blood pressure and blood glucose were well 
controlled, urinalysis was unremarkable, ESR was 54 and CRP 
was 18. Platelets were within normal range. She was commenced 
on oral prednisolone, adcal and lansoprazole and arrangements 
were made for a temporal artery biopsy to be performed. She was 
already taking aspirin. She was given a Fresnel prism to alleviate 
the diplopia.
Temporal artery biopsy (TAB) was challenging and histopathology 
revealed a venular structure had been excised. he diagnosis was 
therefore still not clear two weeks following presentation. Her 
visual acuity had improved to 6/9 in the let eye within this time. 
he high dose oral steroids were disrupting her blood pressure 
and blood sugar control signiicantly and a decision to gradually 
reduce the prednisolone dose was made ater discussions with 
the rheumatology team. Her hypertension and diabetes reverted 
to improved control and the headaches subsided. he sixth nerve 
palsy was almost completely resolved six weeks following the onset 
of the condition. A retrospective diagnosis of microvascular sixth 
nerve palsy was assigned to this vasculopathic patient.
Discussion
he American College of Rheumatology 1990 Criteria classiies 
GCA as follows [1]:
1. Age of onset ≥50 years of age
2. New headache
3. Temporal artery tender/reduced pulsation
4. Elevated ESR, deined as 50mm/h (Westergren method)
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5. Abnormal arterial biopsy – showing necrotising vasculitis with 
predominant mononuclear cell iniltration or granulomatous 
inlammation
his patient was 70 years old, had a new onset headache, temporal 
artery tenderness and absent temporal artery pulsation. Her ESR 
and CRP were raised. he upper limit for normal ESR has also been 
described to increase with age and has been deined as age divided 
by 2 for men and age plus 10 divided by 2 for women. As this lady 
was 70 years old, her upper limit according to this method was 
40mm/h. ESR is traditionally the most important laboratory test for 
GCA. However, there are many reports of patients with a normal 
ESR yet positive temporal artery biopsy. here are also many other 
reasons for this lady who had been recently hospitalised with leg 
ulcers, to have a raised ESR. CRP is an acute phase protein released 
by liver hepatocytes in response to inlammation. It has been found 
that CRP is more speciic for GCA, and that a combination of 
raised ESR and raised CRP is the most speciic [2]. 
GCA predominantly afects Caucasians over 50 years, with 
women afected at least twice as oten as men. Monozygotic 
twin concordance and familial clustering suggests an inherited 
component. he HLA-DR4 haplotype has been associated with 
GCA, as have the intercellular adhesion molecule-1 (ICAM-1) 
genes [3]. 
TAB is the gold standard for diagnosing GCA, yet has limited 
sensitivity, and can be challenging particularly when the artery 
is non-pulsatile due to extensive disease. It is suggested that a 
second biopsy on the opposite side should be performed following 
an unsuccessful irst biopsy, although second attempts only give 
a low positive yield, for example 9% of cases in one study [4]. 
Ultrasonography aids artery detection prior to biopsy, and it has 
been suggested that duplex ultrasonography should be the irst-
line investigation for diagnosing GCA, with biopsy being reserved 
for patients with a negative scan [5]. Although TAB has a low 
complication rate of 0.5%, there is a potential risk of facial nerve 
damage or stroke [6-8]. Halo sign of oedema is a hypoechoic halo 
in the artery wall, and is probably caused by oedema. 
Oral prednisolone is irst-line acute therapy for GCA, but the 
initial starting dose varies widely. Fraser et al recommend a 3-day 
induction dose of IV methylprednisolone at 15mg/kg/d followed 
by oral prednisolone maintenance therapy at 1mg/kg/d initially for 
GCA with visual loss [9]. his is echoed by the Royal College of 
Physicians [10]. Despite treatment with IV corticosteroids, visual 
acuity will reduce in 27% of patients with GCA (mostly within the 
irst six days), however the treatment is efective at reducing the 
likelihood of fellow eye involvement. Without treatment, the risk 
of fellow eye involvement is 54% to 95% [10].
he Royal College of Physicians guideline entitled “Diagnosis and 
management of GCA” includes features to aid early recognition of 
GCA [10]:
1. Abrupt onset headache
2. Scalp tenderness
3. Jaw and tongue claudication
4. Visual symptoms
5. Constitutional symptoms
6. Polymyalgia symptoms
7. Limb claudication
Of these features, the reported patient had only scalp tenderness; 
her presenting features being horizontal diplopia. Extraocular 
motility disorders in GCA are thought to be due to extraocular 
muscle ischaemia caused by thrombotic occlusion of the respective 
muscular arteries [2]. 
GCA is a systemic vasculitis, preferentially involving medium and 
large sized arteries, particularly those of the extracranial branches 
of the carotid artery. It can cause arteritic anterior ischaemic 
optic neuropathy (AAION). Other causes of AAION are rare and 
include polyateritis nodosa, systemic lupus erythematosis and 
herpes zoster. 
he histopathological hallmark of GCA is granulomatous 
inlammation surrounding the internal elastic lamina in medium 
and large vessels. he arterial media is most commonly involved, 
but all three layers may be afected. Macrophages, lymphocytes and 
ibroblasts make up the inlammatory iniltrate. Multinucleated 
giant cells may or may not be present, and are pathognomic of 
disease, fragmenting the internal elastic lamina. Visual loss has 
been associated with presence of giant cells [11]. “Skip lesions” may 
occur due to varied temporal and spatial disease. Inlammation 
leads to local vascular damage and intimal hyperplasia which 
may result in stenosis or occlusion. here is also thought to be an 
angiogenic role in GCA. he multinucleated giant cells produce 
platelet derived growth factor (PDGF) and vascular endothelial 
growth factor (VEGF). Normal arteries have avascular media and 
intima with a capillary network (vasa vasorum) in the adventitia 
only. In GCA, new capillaries appear in the media and intima and 
are more numerous in arteries with luminal stenosis secondary to 
advanced intimal hyperplasia [12]. 
It could be argued that this patient had only minimal visual loss 
and was at low risk of GCA. Visual acuity can be normal in GCA. 
In a study of 123 eyes with visual acuity loss due to GCA, 21% had 
a visual acuity of 6/12 or better. but 62% had a visual acuity of 6/60 
or worse [13]. Conversely, 21% of patients with GCA have occult 
GCA – that is visual loss and a positive temporal artery biopsy 
without any of the systemic features of GCA.
A luorescein angiogram may have aided diagnosis. he main 
lesion in GCA causing visual loss is thrombosis and occlusion 
of the posterior cerebral arteries giving choroidal illing defects. 
However, this must be done in the early stages as collateral 
circulation resolves the illing defects in time. 
Evidence concerning possible increased mortality rate in patients 
with GCA over the normal population is limited and contradictory. 
It seems that death due to cardiovascular disease is increased in 
patients with GCA [14].
Conclusions
he treatment of the reported lady with steroids based on new 
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onset diplopia with a headache with marginally raised ESR and 
CRP is controversial. However, the devastating consequences of 
untreated GCA may warrant a lower threshold for intervention in 
these cases. 
Important points to note:
1. GCA is a challenging diagnosis
2. ESR is a non speciic indicator of inlammation – increases 
in malignancy, infection, CT disorders, trauma, anaemia, 
hypercholesterolaemia
3. CRP and platelet count can help with diagnosing GCA
4. USS for guided biopsy, and potentially for optical biopsy
5. he possible side efects of steroids should not be underestimated.
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